Automatic filtering and substantiation of drug safety signals. by Anna Bauer-Mehren, Erik M van Mullingen, Paul Avillach, María Del Carmen Carrascosa, Ricard Garcia-Serna, Janet Piñero, Bharat Singh, Pedro Lopes, José L Oliveira, Gayo Diallo, Ernst Ahlberg Helgee, Scott Boyer, Jordi Mestres, Ferran Sanz, Jan A Kors, Laura I Furlong

“…Drug safety issues pose serious health threats to the population and constitute a major cause of mortality worldwide. …”
Get full text

Drug Safety and Relevant Issues in the Real-World by Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino

“…The global impact of the COVID-19 pandemic has underscored the pivotal role of drug safety and effective communication within the realm of pharmacovigilance, particularly in times of unprecedented public health emergencies [...]…”
Get full text

Drug Safety Issues in Therapy COVID-19 by D. G. Levitova, S. A. Gracheva, A. S. Samoylov, U. D. Udalov, E. A. Praskurnichiy, O. V. Parinov

Get full text

Clinical and pharmacological monitoring of drug safety in pediatrics by N. V. Verlan, E. O. Kochkina, A. V. Kochkin, L. V. Okhremchuk, A. V. Popadyuk

“…The 95 cases of adverse drug reactions in children were registered in the Centre of Drug Safety Monitoring of Irkutsk Region from 2009 to 2015. …”
Get full text

DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE by Yu. V. Muravyev, L. A. Muravyeva

Subjects: “…drug safety…”
Get full text

Drug safety - Anecdotes that provide definitive evidence by Aronson, J, Hauben, M

Our experience of monitoring of drugs safety in gerontological practice by N. V. Verlan, E. O. Kochkina, A. V. Popadyuk

Get full text

Correction: Automatic Filtering and Substantiation of Drug Safety Signals. by Anna Bauer-Mehren, Erik M. van Mullingen, Paul Avillach, María del Carmen Carrascosa, Ricard Garcia-Serna, Janet Piñero, Bharat Singh, Pedro Lopes, José L. Oliveira, Gayo Diallo, Ernst Ahlberg Helgee, Scott Boyer, Jordi Mestres, Ferran Sanz, Jan A. Kors, Laura I. Furlong

Get full text

Are Drug Safety Advisories Compatible with Physicians’ Information Behaviour? by Mathias Møllebæk, Susanne Kaae

Subjects: Get full text

China’s regional inequity in pharmacist’s drug safety practice by Tang Liyang

“…<p>Abstract</p> <p>Background</p> <p>The promotion of patient safety and drug safety through promotion of pharmacist’s drug safety practice was among the most important aims of China’s health delivery system reform, but regional inequity in pharmacist’s drug safety practice was still serious in China.…”
Get full text

Drug Safety and Suicidality Risk of Chronic Pain Medications by Osman Syed, Predrag Jancic, Adam B. Fink, Nebojsa Nick Knezevic

Subjects: “…drug safety…”
Get full text

XXI century: changes in the Erice Declaration on drug safety by Yu. V. Muravyev, L. A. Muravyeva

Get full text

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance by M. V. Zhuravleva, B. K. Romanov, G. I. Gorodetskaya, O. V. Muslimova, V. S. Krysanova, E. Yu. Demchenkova

Subjects: Get full text

Drug safety among institutionalized elderly people: potential interactions by Maria Lígia Silva Nunes Cavalcante, Renata Kelly Lopes de Alcântara, Isabelly Costa Lima de Oliveira, Samia Freitas Aires, Ana Lívia Araújo Girão, Rhanna Emanuela Fontenele Lima de Carvalho

Get full text

Drug Safety for Children — International Monitoring Data for 50 Years by B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, G. O. Dibirova, N. B. Dmitrieva, I. B. Zhukova, E. V. Kalinina, A. V. Kirillova, N. M. Kiseleva, G. V. Kukushkin, T. I. Leonteva, M. L. Maximov, E. V. Markina, S. E. Mileshina, D. E. Yurov

Get full text

Assessing drug safety by identifying the axis of arrhythmia in cardiomyocyte electrophysiology by Stewart Heitmann, Jamie I Vandenberg, Adam P Hill

Get full text

Application of morbid animal model in drug safety evaluation of TCM by Ning eKe-Yong, Li eMin

Get full text

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities by Elena V. Shubnikova, Marya A. Darmostukova, Irina I. Snegireva, Evgeniya O. Zhuravleva

Get full text

Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects

“…The purpose of this article is to describe and to examine the utility of new pharmacogenetic approaches in monitoring post-approval drug safety in pregnancy. Data on gene expression in pregnancy and metabolic variation may, in specific instances, help to predict adverse drug reactions in the mother-placenta-fetus complex and to identify individuals at a higher risk.…”
Get full text

Comparing epidemiological methods in detecting drug safety signal in IRAN by G Shalviri, K Mohammad, S.R Majdzadeh, K Gholami

Subjects: Get full text